1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Carcinoma, Anaplastic in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, R | 1 |
| Hopp, EA | 1 |
| Decker, NM | 1 |
| Loucks, A | 1 |
| Johnson, JR | 1 |
| Moskal, J | 1 |
| Basu, M | 1 |
| Banerjee, S | 1 |
| Basu, S | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Regulation of glycosyltransferase genes in apoptotic breast cancer cells induced by L: -PPMP and cisplatin.
Topics: Apoptosis; Breast Neoplasms; Carcinoma; Caspase 3; Cell Line, Tumor; Cisplatin; Female; Fluorescent | 2011 |